STEPHANIE MARTIN: Open Payments
NPI 1427225093 · CANTON, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$411 in 29 payments from 7 companies in 2025. Trend: 2023 $597 · 2024 $429 · 2025 $411
Food & beverage: $411
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 18 | $161 |
| Neurocrine BioSciences, Inc. | 3 | $91 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $57 |
| Otsuka America Pharmaceutical, Inc. | 2 | $45 |
| Alkermes, Inc. | 1 | $23 |
| Vanda Pharmaceuticals Inc. | 1 | $18 |
| E.R. Squibb & Sons, L.L.C. | 1 | $15 |
Products named: VRAYLAR, INGREZZA, CAPLYTA, ABILIFY ASIMTUFII, ARISTADA, FANAPT, COBENFY.
Industry payments across OH — which companies pay providers there.
